Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Inoko

Showing results (251-260 of 352) with videos related to

Pageof 36
Sort By:
Immunogenetics|January 1, 1996
Allelic repertoire of the human MHC class I MICA geneN Fodil, L Laloux, V Wanner, et al.
Arthritis and Rheumatism|October 8, 1999
Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's diseaseN Mizuki, M Ota, Y Katsuyama, et al.
Genomics|February 15, 2001
A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III regionM Ota, Y Katsuyama, A Kimura, et al.
Immunogenetics|January 1, 1997
Allelic variants of the human MHC class I chain-related B gene (MICB)H Ando, N Mizuki, M Ota, et al.
The Journal of Clinical Investigation|June 8, 2000
Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic miceK Kawamura, T Yamamura, K Yokoyama, et al.
Human Immunology|June 1, 1995
Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet's diseaseN Mizuki, S Ohno, T Sato, et al.
Gastroenterology|September 1, 1992
HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patientsT Seki, M Ota, S Furuta, et al.
American Journal of Ophthalmology|October 15, 1993
Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101N Mizuki, H Inoko, H Ando, et al.
Molecular and Cellular Biology|July 1, 1997
Precise switching of DNA replication timing in the GC content transition area in the human major histocompatibility complexT Tenzen, T Yamagata, T Fukagawa, et al.
Gene|April 21, 1997
Gene organization of human NOTCH4 and (CTG)n polymorphism in this human counterpart gene of mouse proto-oncogene Int3K Sugaya, S Sasanuma, J Nohata, et al.
Pageof 36

Showing results (251-260 of 352) with videos related to

Sort By:
Pageof 36
Immunogenetics|January 1, 1996
Allelic repertoire of the human MHC class I MICA geneN Fodil, L Laloux, V Wanner, et al.
Arthritis and Rheumatism|October 8, 1999
Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's diseaseN Mizuki, M Ota, Y Katsuyama, et al.
Genomics|February 15, 2001
A second susceptibility gene for developing rheumatoid arthritis in the human MHC is localized within a 70-kb interval telomeric of the TNF genes in the HLA class III regionM Ota, Y Katsuyama, A Kimura, et al.
Immunogenetics|January 1, 1997
Allelic variants of the human MHC class I chain-related B gene (MICB)H Ando, N Mizuki, M Ota, et al.
The Journal of Clinical Investigation|June 8, 2000
Hla-DR2-restricted responses to proteolipid protein 95-116 peptide cause autoimmune encephalitis in transgenic miceK Kawamura, T Yamamura, K Yokoyama, et al.
Human Immunology|June 1, 1995
Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet's diseaseN Mizuki, S Ohno, T Sato, et al.
Gastroenterology|September 1, 1992
HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patientsT Seki, M Ota, S Furuta, et al.
American Journal of Ophthalmology|October 15, 1993
Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101N Mizuki, H Inoko, H Ando, et al.
Molecular and Cellular Biology|July 1, 1997
Precise switching of DNA replication timing in the GC content transition area in the human major histocompatibility complexT Tenzen, T Yamagata, T Fukagawa, et al.
Gene|April 21, 1997
Gene organization of human NOTCH4 and (CTG)n polymorphism in this human counterpart gene of mouse proto-oncogene Int3K Sugaya, S Sasanuma, J Nohata, et al.
Pageof 36